Journey Medical Corp Director's Restricted Stock Units Grant
2025-08-07SEC Filing 4 (0001104659-25-075266)
On August 5, 2025, Jayne Toledano Miranda, a director of Journey Medical Corp (ticker: DERM), was granted 20,000 restricted stock units (RSUs) under the company's 2015 Stock Plan, as amended. These RSUs will vest in three equal installments: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029, and 6,666 shares on August 5, 2030. Following this transaction, Miranda owns a total of 108,618 shares, including previously granted RSUs that are vesting over various periods. The transaction was reported in a Form 4 filing with the SEC on August 7, 2025.
Tickers mentioned in this filing:DERM
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1867066/0001104659-25-075266.txt